Swiss Pharma Giant Roche Buys Telavant Holdings for $7.1 Billion
Swiss pharmaceutical giant Roche has agreed to buy Telavant Holdings, a US-based developer of digital health solutions, for $7.1 billion in …
Swiss pharmaceutical giant Roche has agreed to buy Telavant Holdings, a US-based developer of digital health solutions, for $7.1 billion in …